← Back to Search

UroShield Device for Urinary Tract Infections

N/A
Waitlist Available
Led By Lona Mody
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Antibiotic use in past 10 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up summarized every month for 6 months, or until the recruitment goal is reached.

Summary

"This trial is a small study to test different aspects of a larger study that will happen later. They want to see how easy it is to find and keep participants, how well participants follow the study rules

Who is the study for?
This trial is for adults 18+ with a urinary catheter in place who can follow the study's requirements. They must be able to give written consent or have it provided by their legal representative.
What is being tested?
The study tests the UroShield device, comparing an active version against a sham (inactive) one. It aims to improve quality of life and reduce urinary tract infections, focusing on practical aspects like recruitment, adherence, component replacement frequency, and data collection efficiency.
What are the potential side effects?
Since this is a pilot study primarily focused on feasibility rather than medical outcomes, specific side effects are not detailed. However, potential risks may relate to using the device itself which will be monitored throughout the trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have not taken antibiotics in the last 10 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~summarized every month for 6 months, or until the recruitment goal is reached.
This trial's timeline: 3 weeks for screening, Varies for treatment, and summarized every month for 6 months, or until the recruitment goal is reached. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Recruitment rate
Secondary study objectives
Device accountability
Device use adherence
Efficiency of data collection

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active UroShieldExperimental Treatment1 Intervention
Active UroShield Device
Group II: Sham UroShieldPlacebo Group1 Intervention
Inactive UroShield device

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,857 Previous Clinical Trials
6,437,632 Total Patients Enrolled
2 Trials studying Urinary Tract Infection
240 Patients Enrolled for Urinary Tract Infection
NanovibronixIndustry Sponsor
6 Previous Clinical Trials
451 Total Patients Enrolled
2 Trials studying Urinary Tract Infection
224 Patients Enrolled for Urinary Tract Infection
Lona ModyPrincipal InvestigatorUniversity of Michigan
~12 spots leftby Nov 2025